This is not the most recent version of the article. View current version (20 JUL 2005)

Intervention Protocol

Monoamine oxidase B inhibitors for early Parkinson's disease

  1. AD Macleod,
  2. CE Counsell Clinical Senior Lecturer in Neurology*,
  3. N Ives,
  4. R Stowe

Editorial Group: Cochrane Movement Disorders Group

Published Online: 19 JUL 2004

DOI: 10.1002/14651858.CD004898


How to Cite

Macleod AD, Counsell CE, Ives N, Stowe R. Monoamine oxidase B inhibitors for early Parkinson's disease (Protocol). The Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD004898. DOI: 10.1002/14651858.CD004898.

Author Information

  1. University of Aberdeen, Department of Medicine & Therapeutics, Aberdeen, UK

*CE Counsell, Clinical Senior Lecturer in Neurology, Department of Medicine & Therapeutics, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, AB25 2ZD, UK. carl.counsell@abdn.ac.uk.

Publication History

  1. Published Online: 19 JUL 2004

SEARCH

This is not the most recent version of the article. View current version (20 JUL 2005)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To review the evidence from randomised controlled trials for the efficacy and safety of long-term use of MAO-B inhibitors in patients with early Parkinson's disease.